Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06885073 · ClinicalTrials.gov registry record · NA
Non-invasive Central Venous Pressure Estimation in Pediatric Patients
A NA study of Central Venous Pressure, sponsored by Compremium.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06885073: Recruiting NA study of Central Venous Pressure, sponsored by Compremium.
NCT06885073 is a NA study of Central Venous Pressure that is actively recruiting participants, run by Compremium. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06885073, a NA study of Central Venous Pressure, is actively recruiting participants, sponsored by Compremium.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.
Primary Outcome
Safety: Safety of the device shall be evaluated by systematically reporting DDs, ADEs and SADEs and by monitoring the frequency and incidence of these events. The practitioner will be asked to identify any new risks arising during the measurements using the investigational device.
Conditions Studied
Interventions
- DEVICE CPMX2
Study Locations (1)
District of Columbia
- Children's National Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-03-10 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT06885073 shows while recruiting
NCT06885073 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Central Venous Pressure appearing as the primary indexed condition, and to 1 intervention - of which CPMX2 is the first listed.
NCT06885073 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06885073 about?
NCT06885073 is a clinical study titled "Non-invasive Central Venous Pressure Estimation in Pediatric Patients". Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The pro...
What is the current status of trial NCT06885073?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-03-10. Estimated completion is 2026-03-31.
What conditions does trial NCT06885073 study?
This clinical trial studies the following conditions: Central Venous Pressure.
What interventions are being tested in trial NCT06885073?
The interventions under investigation include: CPMX2 (DEVICE).
Who is sponsoring clinical trial NCT06885073?
This trial is sponsored by Compremium, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06885073 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06885073's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI